Doha, Qatar – 9 April 2018: Aamal Medical – a fully-owned subsidiary of Aamal Company Q.P.S.C., one of the region’s fastest growing diversified companies – has signed an agreement with Simeks Medical (“Simeks”), the Turkish healthcare company, to supply medical equipment with advanced medical technologies.

The signing event took place in Doha and among the attendees were Sheikh Faisal Bin Qassim Al Thani, Chairman of Aamal Company, and Mr. Sherif Shehata (General Manager of Aamal Medical), as well as Mrs. Bahar Sunman (Member of the Board of Simeks) and Mr. Yağız Tüzünalp (Project Sales Manager at Simeks).

Simeks started operating in Turkey in 1999 as the country’s exclusive distributor of ultrasonography, mammography, C-arm x-ray, mobile x-ray and urology products for a major radiology systems manufacturer. In 2000, Simeks took over the sales rights for intensive care and anesthesia devices in Turkey. Simeks focuses on areas such as imaging, operating rooms, intensive care, logistics, IT integration, and medication and supplies management.

Simeks focuses on the optimization of management processing of medication and medical supplies, with the objective of containing major costs in hospitals and helping to prevent medication errors so maximizing patient safety. Furthermore, “Simeks” is also the owner and producer of “Stockart” products; an Automated Medication and Supply Management System whose manufacturing site is located in Izmir, Turkey – distributed in Qatar.   

Commenting, Sheikh Faisal Bin Qassim Al Thani – Chairman of Aamal Company Q.P.S.C. – said: “We are very pleased to announce this agreement with Simeks, a Turkish healthcare systems manufacturing company.  The Agreement is evidence of Aamal’s determination to explore new international markets and to create strong relationships with companies which adhere to the same high quality standards that Aamal sets for all its products and services. We are confident that this agreement will support Aamal Medical’s organic growth by through our proactive approach to partnering with leading institutions to provide the local market with the best and latest medical solutions, so meeting Qatar’s increasing market needs. I would also highlight that the assembly of medical equipment will take place locally, an initiative which will add to the prosperity and self- sufficiency of our beloved country”.

Mr. Sherif Shehata – General Manager of Aamal Medical – commented: “I’m pleased to announce this partnership Simeks, a leading medical firm. This agreement demonstrates our determination and commitment to secure medical equipment availability in Qatar from different sources, including Turkey which has recently provided strong support to the Qatari market. Our partnership with Simeks is the result of our rigorous search for a well-established partner in Turkey and provides us with an excellent opportunity to expand our product offering and, ultimately, to achieve medical self-sufficiency”.

Mrs. Bahar Sunman – Member of the Board of Simeks – commented: “We intend to address the needs of the Qatari healthcare market with the utmost commitment. We believe that the combination of Turkish and Qatari engineers will result in exceptional output and a very successful offering.”

-Ends-

For further enquiries, please contact:

Aamal Company Q.P.S.C.: +974 44350666

Arwa Goussous –Corporate Communications Manager

(+97455139539 / arwa.goussous@aamal.com.qa)

Laura Ackel – Marketing and Communications Officer

(+97466716576 / laura.ackel@aamal.com.qa)

Aamal Company Q.P.S.C.:

Aamal is one of the GCC’s fastest growing diversified conglomerates and has been listed on the Qatar Stock Exchange since December 2007. As of April 8th, 2018, the Company had a market capitalization of around QAR 6.1 billion (US$ 1.67 billion).

Focused on self-financed and profitable growth, Aamal’s operations are widely diversified and currently comprise 24 active business units with market leading positions in the key industrial, retail, property, managed services, and medical equipment and pharmaceutical sectors, thereby offering investors a high quality and balanced exposure to Qatar’s wider economic growth and development. Over the ten years to end-2016, the Company has delivered a compound annual growth rate in trading net profit (i.e. before fair value gains on investment properties) slightly below 19% a year, with minimal financial leverage.

For further information on Aamal Company, please refer to the corporate website: http://www.aamal.com.qa

Aamal Medical Company:

Aamal Medical is one of the leading medical equipment suppliers in Qatar, specializing in the sale of medical equipment, medical and surgical consumables, hospital furniture, spare parts and consumables, as well as healthcare and IT solutions to healthcare facilities and providing full-service maintenance contracts to customers. Aamal Medical also offers complete integrated solutions such as hospital information systems, enterprise resource planning solutions for healthcare, integrated operating theatres and total integrity pharmacy robotic systems.

Aamal Medical works with over 50 medical equipment suppliers from all over the world and is the exclusive agent for major international and well-known suppliers such as Karl Storz, Covidien, Alcon and Cardinal Health.

Aamal Medical caters to a wide base of customers in the medical sector – including government, semi-government and private sectors – and to the development of the healthcare sector. It is expected that its market share will increase as more projects are implemented.